Cryolife Stock Downgraded (CRY)
- The revenue growth came in higher than the industry average of 4.4%. Since the same quarter one year prior, revenues slightly increased by 7.0%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- CRY has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. To add to this, CRY has a quick ratio of 1.91, which demonstrates the ability of the company to cover short-term liquidity needs.
- The gross profit margin for CRYOLIFE INC is currently very high, coming in at 70.20%. It has increased from the same quarter the previous year. Despite the strong results of the gross profit margin, CRY's net profit margin of 3.10% significantly trails the industry average.
- Net operating cash flow has significantly decreased to $1.81 million or 53.31% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income has significantly decreased by 40.5% when compared to the same quarter one year ago, falling from $1.67 million to $0.99 million.
-- Written by a member of TheStreet Ratings Staff
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.